220 related articles for article (PubMed ID: 10897101)
1. Beta-agonist-induced alterations in organ weights and protein content: comparison of racemic clenbuterol and its enantiomers.
von Deutsch DA; Abukhalaf IK; Wineski LE; Aboul-Enein HY; Pitts SA; Parks BA; Oster RA; Paulsen DF; Potter DE
Chirality; 2000 Aug; 12(8):637-48. PubMed ID: 10897101
[TBL] [Abstract][Full Text] [Related]
2. "beta-Agonist-induced alterations in organ weights and protein content: comparisons of racemic clenbuterol and its enantiomers.".
Smith DJ
Chirality; 2001 Jun; 13(6):279-84. PubMed ID: 11370015
[No Abstract] [Full Text] [Related]
3. Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats.
Bonnet N; Benhamou CL; Brunet-Imbault B; Arlettaz A; Horcajada MN; Richard O; Vico L; Collomp K; Courteix D
Bone; 2005 Nov; 37(5):622-33. PubMed ID: 16157516
[TBL] [Abstract][Full Text] [Related]
4. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
[TBL] [Abstract][Full Text] [Related]
5. Clenbuterol attenuates muscle atrophy and dysfunction in hindlimb-suspended rats.
Dodd SL; Koesterer TJ
Aviat Space Environ Med; 2002 Jul; 73(7):635-9. PubMed ID: 12137098
[TBL] [Abstract][Full Text] [Related]
6. Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support.
George I; Xydas S; Mancini DM; Lamanca J; DiTullio M; Marboe CC; Shane E; Schulman AR; Colley PM; Petrilli CM; Naka Y; Oz MC; Maybaum S
J Heart Lung Transplant; 2006 Sep; 25(9):1084-90. PubMed ID: 16962470
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective disposition of clenbuterol in rats.
Hirosawa I; Ishikawa M; Ogino M; Ito H; Hirao T; Yamada H; Asahi M; Kotaki H; Sai Y; Miyamoto K
Biopharm Drug Dispos; 2014 May; 35(4):207-17. PubMed ID: 24323748
[TBL] [Abstract][Full Text] [Related]
8. Preservation of denervated muscle form and function by clenbuterol in a rat model of peripheral nerve injury.
Fitton AR; Berry MS; McGregor AD
J Hand Surg Br; 2001 Aug; 26(4):335-46. PubMed ID: 11469836
[TBL] [Abstract][Full Text] [Related]
9. Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats.
Duncan ND; Williams DA; Lynch GS
Clin Sci (Lond); 2000 Mar; 98(3):339-47. PubMed ID: 10677393
[TBL] [Abstract][Full Text] [Related]
10. Histological evidences of reparative and regenerative effects of beta-adrenoceptor agonists, clenbuterol and isoproterenol, in denervated rat skeletal muscle.
Katoch SS; Garg A; Sharma S
Indian J Exp Biol; 2006 Jun; 44(6):448-58. PubMed ID: 16784115
[TBL] [Abstract][Full Text] [Related]
11. The effect of the beta2-adrenoceptor agonist prodrug BRL-47672 on cardiovascular function, skeletal muscle myosin heavy chain, and MyoD expression in the rat.
Jones SW; Baker DJ; Gardiner SM; Bennett T; Timmons JA; Greenhaff PL
J Pharmacol Exp Ther; 2004 Dec; 311(3):1225-31. PubMed ID: 15243031
[TBL] [Abstract][Full Text] [Related]
12. Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle-aged rats.
Suzuki J; Gao M; Xie Z; Koyama T
Acta Physiol Scand; 1997 Nov; 161(3):317-26. PubMed ID: 9401584
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and physiologic characteristics of skeletal muscle determine its response to clenbuterol treatment.
Sundal S; Katoch SS; Sharma S
Indian J Biochem Biophys; 2006 Jun; 43(3):160-6. PubMed ID: 16967905
[TBL] [Abstract][Full Text] [Related]
14. Effects of the beta2-agonist clenbuterol on beta1- and beta2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles.
Sato S; Nomura S; Kawano F; Tanihata J; Tachiyashiki K; Imaizumi K
J Pharmacol Sci; 2008 Aug; 107(4):393-400. PubMed ID: 18678986
[TBL] [Abstract][Full Text] [Related]
15. Altered mRNA abundance of ASB15 and four other genes in skeletal muscle following administration of beta-adrenergic receptor agonists.
McDaneld TG; Hancock DL; Moody DE
Physiol Genomics; 2004 Jan; 16(2):275-83. PubMed ID: 14645738
[TBL] [Abstract][Full Text] [Related]
16. Effect of beta2-adrenergic agonist clenbuterol on ischemia/reperfusion injury in isolated rat hearts and cardiomyocyte apoptosis induced by hydrogen peroxide.
Liu P; Xiang JZ; Zhao L; Yang L; Hu BR; Fu Q
Acta Pharmacol Sin; 2008 Jun; 29(6):661-9. PubMed ID: 18501112
[TBL] [Abstract][Full Text] [Related]
17. Clenbuterol increases muscle fiber size and GATA-2 protein in rat skeletal muscle in utero.
Downie D; Delday MI; Maltin CA; Sneddon AA
Mol Reprod Dev; 2008 May; 75(5):785-94. PubMed ID: 17948249
[TBL] [Abstract][Full Text] [Related]
18. Enantio-selective effects of clenbuterol in cultured neurons and astrocytes, and in a mouse model of cerebral ischemia.
Culmsee C; Junker V; Thal S; Kremers W; Maier S; Schneider HJ; Plesnila N; Krieglstein J
Eur J Pharmacol; 2007 Dec; 575(1-3):57-65. PubMed ID: 17869242
[TBL] [Abstract][Full Text] [Related]
19. [Effect of a beta-agonist and a beta-agonist/beta-antagonist combination on muscle growth, body composition and protein metabolism in rats].
Reichel K; Rehfeldt C; Weikard R; Schadereit R; Krawielitzki K
Arch Tierernahr; 1993; 45(3):211-25. PubMed ID: 8585791
[TBL] [Abstract][Full Text] [Related]
20. Distribution and muscle-sparing effects of clenbuterol in hindlimb-suspended rats.
von Deutsch DA; Abukhalaf IK; Wineski LE; Roper RR; Aboul-Enein HY; Paulsen DF; Potter DE
Pharmacology; 2002 May; 65(1):38-48. PubMed ID: 11901300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
